Skip to main content
Erschienen in: Arthritis Research & Therapy 4/2011

01.12.2011 | Review

Disturbance of cytokine networks in Sjögren's syndrome

verfasst von: Pierre Youinou, Jacques-Olivier Pers

Erschienen in: Arthritis Research & Therapy | Ausgabe 4/2011

Einloggen, um Zugang zu erhalten

Abstract

The difficulty in predicting the consequences of interactions between different cytokine networks has increased with the expansion of the T helper (Th) cell universe and the discovery of numerous B lymphocyte-derived cytokines. Consequently, it is now difficult to conceptualize a straightforward view of the contribution of these disturbances to the pathogenesis of primary Sjögren's syndrome (SS). Th1 cells, which produce interferon-γ and IL-2, and Th17 cells, which make IL-17 and TNF-α, have been cast in the leading roles of the play. However, the complex role of T-cell subsets in SS is accentuated by the reciprocal effects of Th17 cells and regulatory T cells found in salivary glands of SS patients. Furthermore, B lymphocyte polarization into type-1 B effector (Be1) and Be2 cells and B-cell modulating factors of the TNF family, most notably the B-cell-activating factor (BAFF), and their prominent role in SS are additional complicating factors. Whereas Th17 cells orchestrate autoreactive germinal centers, local BAFF would repress the generation of Th17 cells. Such new insights into interconnected cytokines in primary SS may lead to new treatments for these patients.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Moutsopoulos HM: Sjögren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol. 1994, 72: 162-165. 10.1006/clin.1994.1123.CrossRefPubMed Moutsopoulos HM: Sjögren's syndrome: autoimmune epithelitis. Clin Immunol Immunopathol. 1994, 72: 162-165. 10.1006/clin.1994.1123.CrossRefPubMed
2.
Zurück zum Zitat Gershwin ME: The mosaic of autoimmunity. Autoimmun Rev. 2008, 7: 161-163. 10.1016/j.autrev.2007.11.021.CrossRefPubMed Gershwin ME: The mosaic of autoimmunity. Autoimmun Rev. 2008, 7: 161-163. 10.1016/j.autrev.2007.11.021.CrossRefPubMed
3.
Zurück zum Zitat Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM: Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. J Autoimmun. 2010, 34: 400-407. 10.1016/j.jaut.2009.10.004.CrossRefPubMed Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM: Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome. J Autoimmun. 2010, 34: 400-407. 10.1016/j.jaut.2009.10.004.CrossRefPubMed
4.
Zurück zum Zitat d'Arbonneau F, Pers JO, Devauchelle V, Pennec Y, Saraux A, Youinou P: BAFF-induced changes in BCR-containing lipid rafts in Sjögren's syndrome. Arthritis Rheum. 2006, 54: 115-126. 10.1002/art.21478.CrossRefPubMed d'Arbonneau F, Pers JO, Devauchelle V, Pennec Y, Saraux A, Youinou P: BAFF-induced changes in BCR-containing lipid rafts in Sjögren's syndrome. Arthritis Rheum. 2006, 54: 115-126. 10.1002/art.21478.CrossRefPubMed
5.
Zurück zum Zitat Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C: Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome. J Clin Invest. 1998, 102: 938-946. 10.1172/JCI3234.PubMedCentralCrossRefPubMed Stott DI, Hiepe F, Hummel M, Steinhauser G, Berek C: Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. The salivary glands of patients with Sjögren's syndrome. J Clin Invest. 1998, 102: 938-946. 10.1172/JCI3234.PubMedCentralCrossRefPubMed
6.
Zurück zum Zitat Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, Wahren-Herlenius M, Jonsson R: Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum. 2003, 48: 3187-3201. 10.1002/art.11311.CrossRefPubMed Salomonsson S, Jonsson MV, Skarstein K, Brokstad KA, Hjelmstrom P, Wahren-Herlenius M, Jonsson R: Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjögren's syndrome. Arthritis Rheum. 2003, 48: 3187-3201. 10.1002/art.11311.CrossRefPubMed
7.
Zurück zum Zitat Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, Challacombe SJ, Valesini G, Pitzalis C: Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. Arthritis Rheum. 2005, 52: 1773-1784. 10.1002/art.21062.CrossRefPubMed Barone F, Bombardieri M, Manzo A, Blades MC, Morgan PR, Challacombe SJ, Valesini G, Pitzalis C: Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjögren's syndrome. Arthritis Rheum. 2005, 52: 1773-1784. 10.1002/art.21062.CrossRefPubMed
8.
Zurück zum Zitat Hansen A, Lipsky PE, Dőrner T: Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy. Curr Opin Rheumatol. 2005, 17: 558-565. 10.1097/01.bor.0000172801.56744.c3.CrossRefPubMed Hansen A, Lipsky PE, Dőrner T: Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy. Curr Opin Rheumatol. 2005, 17: 558-565. 10.1097/01.bor.0000172801.56744.c3.CrossRefPubMed
9.
Zurück zum Zitat Gor DO, Rose NR, Greenspan NS: Th1-Th2: a procrustean paradigm. Nat Immunol. 2003, 4: 503-505.CrossRefPubMed Gor DO, Rose NR, Greenspan NS: Th1-Th2: a procrustean paradigm. Nat Immunol. 2003, 4: 503-505.CrossRefPubMed
10.
Zurück zum Zitat Mosmann TR, Coffman RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989, 7: 145-173. 10.1146/annurev.iy.07.040189.001045.CrossRefPubMed Mosmann TR, Coffman RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989, 7: 145-173. 10.1146/annurev.iy.07.040189.001045.CrossRefPubMed
11.
Zurück zum Zitat Miossec P, Korn T, Kuchroo VK: Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009, 361: 888-898. 10.1056/NEJMra0707449.CrossRefPubMed Miossec P, Korn T, Kuchroo VK: Interleukin-17 and type 17 helper T cells. N Engl J Med. 2009, 361: 888-898. 10.1056/NEJMra0707449.CrossRefPubMed
12.
Zurück zum Zitat Sakaguchi S, Yamaguchi T, Nomura T, Ono M: Regulatory T cells and immune tolerance. Cell. 2008, 133: 775-787. 10.1016/j.cell.2008.05.009.CrossRefPubMed Sakaguchi S, Yamaguchi T, Nomura T, Ono M: Regulatory T cells and immune tolerance. Cell. 2008, 133: 775-787. 10.1016/j.cell.2008.05.009.CrossRefPubMed
13.
Zurück zum Zitat Saraux A: The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome. Autoimmun Rev. 2010, 9: 609-614. 10.1016/j.autrev.2010.05.007.CrossRefPubMed Saraux A: The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome. Autoimmun Rev. 2010, 9: 609-614. 10.1016/j.autrev.2010.05.007.CrossRefPubMed
14.
Zurück zum Zitat Youinou P, Devauchelle V, Pers JO: Significance of B cells and B cell clonality in Sjögren's syndrome. Arthritis Rheum. 2010, 62: 2605-2610. 10.1002/art.27564.CrossRefPubMed Youinou P, Devauchelle V, Pers JO: Significance of B cells and B cell clonality in Sjögren's syndrome. Arthritis Rheum. 2010, 62: 2605-2610. 10.1002/art.27564.CrossRefPubMed
15.
Zurück zum Zitat Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, Johnson LL, Swain SL, Lund FE: Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol. 2000, 1: 475-482. 10.1038/82717.CrossRefPubMed Harris DP, Haynes L, Sayles PC, Duso DK, Eaton SM, Lepak NM, Johnson LL, Swain SL, Lund FE: Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol. 2000, 1: 475-482. 10.1038/82717.CrossRefPubMed
16.
Zurück zum Zitat Jamin C, Morva A, Lemoine S, Daridon C, Revol de Mendoza A, Youinou P: Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum. 2008, 58: 1900-1906. 10.1002/art.23487.CrossRefPubMed Jamin C, Morva A, Lemoine S, Daridon C, Revol de Mendoza A, Youinou P: Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum. 2008, 58: 1900-1906. 10.1002/art.23487.CrossRefPubMed
17.
Zurück zum Zitat Mackay F, Silveira PA, Brink R: B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin Immunol. 2007, 19: 327-336. 10.1016/j.coi.2007.04.008.CrossRefPubMed Mackay F, Silveira PA, Brink R: B cells and the BAFF/APRIL axis: fast-forward on autoimmunity and signaling. Curr Opin Immunol. 2007, 19: 327-336. 10.1016/j.coi.2007.04.008.CrossRefPubMed
18.
Zurück zum Zitat Szodoray P, Alex P, Brun JG, Centola M, Jonsson R: Circulating cytokines in primary Sjögren's syndrome determined by a multiplex cytokine array system. Scand J Immunol. 2004, 59: 592-599. 10.1111/j.0300-9475.2004.01432.x.CrossRefPubMed Szodoray P, Alex P, Brun JG, Centola M, Jonsson R: Circulating cytokines in primary Sjögren's syndrome determined by a multiplex cytokine array system. Scand J Immunol. 2004, 59: 592-599. 10.1111/j.0300-9475.2004.01432.x.CrossRefPubMed
19.
Zurück zum Zitat Crane IJ, Forrester JV: Th1 and Th2 lymphocytes in autoimmune disease. Crit Rev Immunol. 2005, 25: 75-102. 10.1615/CritRevImmunol.v25.i2.10.CrossRefPubMed Crane IJ, Forrester JV: Th1 and Th2 lymphocytes in autoimmune disease. Crit Rev Immunol. 2005, 25: 75-102. 10.1615/CritRevImmunol.v25.i2.10.CrossRefPubMed
20.
Zurück zum Zitat Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL: Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med. 1979, 301: 5-8. 10.1056/NEJM197907053010102.CrossRefPubMed Hooks JJ, Moutsopoulos HM, Geis SA, Stahl NI, Decker JL, Notkins AL: Immune interferon in the circulation of patients with autoimmune disease. N Engl J Med. 1979, 301: 5-8. 10.1056/NEJM197907053010102.CrossRefPubMed
21.
Zurück zum Zitat Hagiwara E, Pando J, Ishigatsubo Y, Klinman DM: Altered frequency of type-1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome. J Rheumatol. 1998, 25: 89-93.PubMed Hagiwara E, Pando J, Ishigatsubo Y, Klinman DM: Altered frequency of type-1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome. J Rheumatol. 1998, 25: 89-93.PubMed
22.
Zurück zum Zitat Boumba D, Skopouli FN, Moutsopoulos HM: Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Br J Rheumatol. 1995, 34: 326-333. 10.1093/rheumatology/34.4.326.CrossRefPubMed Boumba D, Skopouli FN, Moutsopoulos HM: Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren's syndrome. Br J Rheumatol. 1995, 34: 326-333. 10.1093/rheumatology/34.4.326.CrossRefPubMed
23.
Zurück zum Zitat Wakamatsu E, Matsumoto I, Yasukochi T, Naito Y, Goto D, Mamura M, Ito S, Tsutsumi A, Sumida T: Overexpression of Stat-1α in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 2006, 54: 3476-3484. 10.1002/art.22176.CrossRefPubMed Wakamatsu E, Matsumoto I, Yasukochi T, Naito Y, Goto D, Mamura M, Ito S, Tsutsumi A, Sumida T: Overexpression of Stat-1α in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 2006, 54: 3476-3484. 10.1002/art.22176.CrossRefPubMed
24.
Zurück zum Zitat van Woerkom JM, Kruize AA, Wenting-van Wijk MJ, Knol E, Bihari IC, Jacobs JW, Bijlsma JW, Lafeber FP, van Roon JA: Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome. Ann Rheum Dis. 2005, 64: 1474-1479. 10.1136/ard.2004.031781.PubMedCentralCrossRefPubMed van Woerkom JM, Kruize AA, Wenting-van Wijk MJ, Knol E, Bihari IC, Jacobs JW, Bijlsma JW, Lafeber FP, van Roon JA: Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome. Ann Rheum Dis. 2005, 64: 1474-1479. 10.1136/ard.2004.031781.PubMedCentralCrossRefPubMed
25.
Zurück zum Zitat Mitsias DI, Tzioufas AG, Veiopoulou C, Zintzaras E, Tassios IK, Kogopoulou O, Moutsopoulos HM, Thyphronitis G: The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjögren's syndrome. Clin Exp Immunol. 2002, 128: 562-568. 10.1046/j.1365-2249.2002.01869.x.PubMedCentralCrossRefPubMed Mitsias DI, Tzioufas AG, Veiopoulou C, Zintzaras E, Tassios IK, Kogopoulou O, Moutsopoulos HM, Thyphronitis G: The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjögren's syndrome. Clin Exp Immunol. 2002, 128: 562-568. 10.1046/j.1365-2249.2002.01869.x.PubMedCentralCrossRefPubMed
26.
Zurück zum Zitat Bombardieri M, Barone F, Pittoni V, Alessandri C, Conigliaro P, Blades MC, Priori R, McInnes IB, Valesini G, Pitzalis C: Increased circulating levels and salivary gland expression of IL-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther. 2004, 6: R447-456. 10.1186/ar1209.PubMedCentralCrossRefPubMed Bombardieri M, Barone F, Pittoni V, Alessandri C, Conigliaro P, Blades MC, Priori R, McInnes IB, Valesini G, Pitzalis C: Increased circulating levels and salivary gland expression of IL-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate. Arthritis Res Ther. 2004, 6: R447-456. 10.1186/ar1209.PubMedCentralCrossRefPubMed
27.
Zurück zum Zitat Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S: Identification of IL-18 and Th17 cells in salivary glands of Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol. 2008, 181: 2898-2906.CrossRefPubMed Sakai A, Sugawara Y, Kuroishi T, Sasano T, Sugawara S: Identification of IL-18 and Th17 cells in salivary glands of Sjögren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. J Immunol. 2008, 181: 2898-2906.CrossRefPubMed
28.
Zurück zum Zitat McInnes IB, Gracie JA, Leung BP, Wei XQ, Liew FY: Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today. 2000, 21: 312-315. 10.1016/S0167-5699(00)01648-0.CrossRefPubMed McInnes IB, Gracie JA, Leung BP, Wei XQ, Liew FY: Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today. 2000, 21: 312-315. 10.1016/S0167-5699(00)01648-0.CrossRefPubMed
29.
Zurück zum Zitat Dardalhon V, Korn T, Kuchroo VK, Anderson AC: Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun. 2008, 31: 252-256. 10.1016/j.jaut.2008.04.017.PubMedCentralCrossRefPubMed Dardalhon V, Korn T, Kuchroo VK, Anderson AC: Role of Th1 and Th17 cells in organ-specific autoimmunity. J Autoimmun. 2008, 31: 252-256. 10.1016/j.jaut.2008.04.017.PubMedCentralCrossRefPubMed
30.
31.
Zurück zum Zitat Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB: Salivary gland tissue expression of IL-23 and IL-17 in Sjögren's syndrome: findings in humans and mice. Arthritis Rheum. 2008, 58: 734-743. 10.1002/art.23214.PubMedCentralCrossRefPubMed Nguyen CQ, Hu MH, Li Y, Stewart C, Peck AB: Salivary gland tissue expression of IL-23 and IL-17 in Sjögren's syndrome: findings in humans and mice. Arthritis Rheum. 2008, 58: 734-743. 10.1002/art.23214.PubMedCentralCrossRefPubMed
32.
Zurück zum Zitat Mitsdoerffer M, Lee Y, Jager A, Kim HJ, Korn T, Kolls JK, Cantor H, Bettelli E, Kuchroo VK: Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci USA. 2010, 107: 14292-14297. 10.1073/pnas.1009234107.PubMedCentralCrossRefPubMed Mitsdoerffer M, Lee Y, Jager A, Kim HJ, Korn T, Kolls JK, Cantor H, Bettelli E, Kuchroo VK: Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci USA. 2010, 107: 14292-14297. 10.1073/pnas.1009234107.PubMedCentralCrossRefPubMed
33.
Zurück zum Zitat Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM: Systemic and local IL-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis. Am J Pathol. 2009, 175: 1167-1177. 10.2353/ajpath.2009.090319.PubMedCentralCrossRefPubMed Katsifis GE, Rekka S, Moutsopoulos NM, Pillemer S, Wahl SM: Systemic and local IL-17 and linked cytokines associated with Sjögren's syndrome immunopathogenesis. Am J Pathol. 2009, 175: 1167-1177. 10.2353/ajpath.2009.090319.PubMedCentralCrossRefPubMed
34.
Zurück zum Zitat Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, Qin FX, Gilliet M, Liu YJ: Two functional subsets of Foxp3+ regulatory T cells in human thymus and periphery. Immunity. 2008, 28: 870-880. 10.1016/j.immuni.2008.03.018.PubMedCentralCrossRefPubMed Ito T, Hanabuchi S, Wang YH, Park WR, Arima K, Bover L, Qin FX, Gilliet M, Liu YJ: Two functional subsets of Foxp3+ regulatory T cells in human thymus and periphery. Immunity. 2008, 28: 870-880. 10.1016/j.immuni.2008.03.018.PubMedCentralCrossRefPubMed
35.
Zurück zum Zitat Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, Taoufik Y, Mariette X: CD4+CD25 high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. J Autoimmun. 2005, 24: 235-242. 10.1016/j.jaut.2005.01.015.CrossRefPubMed Gottenberg JE, Lavie F, Abbed K, Gasnault J, Le Nevot E, Delfraissy JF, Taoufik Y, Mariette X: CD4+CD25 high regulatory T cells are not impaired in patients with primary Sjögren's syndrome. J Autoimmun. 2005, 24: 235-242. 10.1016/j.jaut.2005.01.015.CrossRefPubMed
36.
Zurück zum Zitat Liu MF, Lin LH, Weng CT, Weng MY: Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjögren's syndrome. Lupus. 2008, 17: 34-39. 10.1177/0961203307085248.CrossRefPubMed Liu MF, Lin LH, Weng CT, Weng MY: Decreased CD4+CD25+bright T cells in peripheral blood of patients with primary Sjögren's syndrome. Lupus. 2008, 17: 34-39. 10.1177/0961203307085248.CrossRefPubMed
37.
Zurück zum Zitat Christodoulou MI, Kapsogeorgou EK, Moutsopoulos NM, Moutsopoulos HM: Foxp3+ T-regulatory cells in Sjögren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am J Pathol. 2008, 173: 1389-1396. 10.2353/ajpath.2008.080246.PubMedCentralCrossRefPubMed Christodoulou MI, Kapsogeorgou EK, Moutsopoulos NM, Moutsopoulos HM: Foxp3+ T-regulatory cells in Sjögren's syndrome: correlation with the grade of the autoimmune lesion and certain adverse prognostic factors. Am J Pathol. 2008, 173: 1389-1396. 10.2353/ajpath.2008.080246.PubMedCentralCrossRefPubMed
38.
Zurück zum Zitat Youinou P, Jamin C: The weight of IL-6 in B cell-related autoimmune disorders. J Autoimmun. 2009, 32: 206-210. 10.1016/j.jaut.2009.02.013.CrossRefPubMed Youinou P, Jamin C: The weight of IL-6 in B cell-related autoimmune disorders. J Autoimmun. 2009, 32: 206-210. 10.1016/j.jaut.2009.02.013.CrossRefPubMed
39.
Zurück zum Zitat Nishimoto N, Kishimoto T: Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol. 2006, 2: 619-626. 10.1038/ncprheum0338.CrossRefPubMed Nishimoto N, Kishimoto T: Interleukin 6: from bench to bedside. Nat Clin Pract Rheumatol. 2006, 2: 619-626. 10.1038/ncprheum0338.CrossRefPubMed
40.
Zurück zum Zitat Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, Yi J, Guentert T, Tousson A, Stanus AL, Le TV, Lorenz RG, Xu H, Kolls JK, Carter RH, Chaplin DD, Williams RW, Mountz JD: IL-17-producing T helper cells and IL-17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol. 2008, 9: 166-175. 10.1038/ni1552.CrossRefPubMed Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, Yi J, Guentert T, Tousson A, Stanus AL, Le TV, Lorenz RG, Xu H, Kolls JK, Carter RH, Chaplin DD, Williams RW, Mountz JD: IL-17-producing T helper cells and IL-17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nat Immunol. 2008, 9: 166-175. 10.1038/ni1552.CrossRefPubMed
41.
Zurück zum Zitat Le Pottier L, Devauchelle V, Fautrel A, Daridon C, Saraux A, Youinou P, Pers JO: Ectopic germinal centers are rare in Sjögren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol. 2009, 182: 3540-3547. 10.4049/jimmunol.0803588.CrossRefPubMed Le Pottier L, Devauchelle V, Fautrel A, Daridon C, Saraux A, Youinou P, Pers JO: Ectopic germinal centers are rare in Sjögren's syndrome salivary glands and do not exclude autoreactive B cells. J Immunol. 2009, 182: 3540-3547. 10.4049/jimmunol.0803588.CrossRefPubMed
42.
Zurück zum Zitat Hillion S, Dueymes M, Youinou P, Jamin C: IL-6 contributes to the expression of Rags in human mature B cells. J Immunol. 2007, 179: 6790-6798.CrossRefPubMed Hillion S, Dueymes M, Youinou P, Jamin C: IL-6 contributes to the expression of Rags in human mature B cells. J Immunol. 2007, 179: 6790-6798.CrossRefPubMed
43.
Zurück zum Zitat Kitani A, Hara M, Hirose T, Harigai M, Suzuki K, Kawakami M, Kawaguchi Y, Hidaka T, Kawagoe M, Nakamura H: Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with SLE: analysis of IL-6 production and IL-6R expression. Clin Exp Immunol. 1992, 88: 75-83.PubMedCentralCrossRefPubMed Kitani A, Hara M, Hirose T, Harigai M, Suzuki K, Kawakami M, Kawaguchi Y, Hidaka T, Kawagoe M, Nakamura H: Autostimulatory effects of IL-6 on excessive B cell differentiation in patients with SLE: analysis of IL-6 production and IL-6R expression. Clin Exp Immunol. 1992, 88: 75-83.PubMedCentralCrossRefPubMed
44.
Zurück zum Zitat Bikker A, van Woerkom JM, Kruize AA, Wenting-van Wijk M, de Jager W, Bijlsma JW, Lafeber FP, van Roon JA: Increased expression of IL-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation. Arthritis Rheum. 2010, 62: 969-977. 10.1002/art.27318.CrossRefPubMed Bikker A, van Woerkom JM, Kruize AA, Wenting-van Wijk M, de Jager W, Bijlsma JW, Lafeber FP, van Roon JA: Increased expression of IL-7 in labial salivary glands of patients with primary Sjögren's syndrome correlates with increased inflammation. Arthritis Rheum. 2010, 62: 969-977. 10.1002/art.27318.CrossRefPubMed
45.
Zurück zum Zitat Harris DP, Goodrich S, Mohrs K, Mohrs M, Lund FE: The development of IL-4-producing B cells is controlled by IL-4, IL-4R α, and Th2 cells. J Immunol. 2005, 175: 7103-7107.CrossRefPubMed Harris DP, Goodrich S, Mohrs K, Mohrs M, Lund FE: The development of IL-4-producing B cells is controlled by IL-4, IL-4R α, and Th2 cells. J Immunol. 2005, 175: 7103-7107.CrossRefPubMed
46.
Zurück zum Zitat Ettinger R, Browning JL, Michie SA, van Ewijk W, McDevitt HO: Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble LTβ receptor-IgG1 fusion protein. Proc Natl Acad Sci USA. 1996, 93: 13102-13107. 10.1073/pnas.93.23.13102.PubMedCentralCrossRefPubMed Ettinger R, Browning JL, Michie SA, van Ewijk W, McDevitt HO: Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble LTβ receptor-IgG1 fusion protein. Proc Natl Acad Sci USA. 1996, 93: 13102-13107. 10.1073/pnas.93.23.13102.PubMedCentralCrossRefPubMed
47.
Zurück zum Zitat Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS: Surface LTα/β complex is required for the development of peripheral lymphoid organs. J Exp Med. 1996, 184: 1999-2006. 10.1084/jem.184.5.1999.CrossRefPubMed Rennert PD, Browning JL, Mebius R, Mackay F, Hochman PS: Surface LTα/β complex is required for the development of peripheral lymphoid organs. J Exp Med. 1996, 184: 1999-2006. 10.1084/jem.184.5.1999.CrossRefPubMed
48.
Zurück zum Zitat Mackay F, Majeau GR, Lawton P, Hochman PS, Browning JL: Lymphotoxin but not TNF functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur J Immunol. 1997, 27: 2033-2042. 10.1002/eji.1830270830.CrossRefPubMed Mackay F, Majeau GR, Lawton P, Hochman PS, Browning JL: Lymphotoxin but not TNF functions to maintain splenic architecture and humoral responsiveness in adult mice. Eur J Immunol. 1997, 27: 2033-2042. 10.1002/eji.1830270830.CrossRefPubMed
49.
Zurück zum Zitat Gonzalez M, Mackay F, Browning JL, Kosco-Vilbois MH, Noelle RJ: The sequential role of LT and B cells in the development of splenic follicles. J Exp Med. 1998, 187: 997-1007. 10.1084/jem.187.7.997.PubMedCentralCrossRefPubMed Gonzalez M, Mackay F, Browning JL, Kosco-Vilbois MH, Noelle RJ: The sequential role of LT and B cells in the development of splenic follicles. J Exp Med. 1998, 187: 997-1007. 10.1084/jem.187.7.997.PubMedCentralCrossRefPubMed
50.
Zurück zum Zitat Gatumu MK, Skarstein K, Papandile A, Browning JL, Fava RA, Bolstad AI: Blockade of LTβ receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of NOD mice. Arthritis Res Ther. 2009, 11: R24-10.1186/ar2617.PubMedCentralCrossRefPubMed Gatumu MK, Skarstein K, Papandile A, Browning JL, Fava RA, Bolstad AI: Blockade of LTβ receptor signaling reduces aspects of Sjögren's syndrome in salivary glands of NOD mice. Arthritis Res Ther. 2009, 11: R24-10.1186/ar2617.PubMedCentralCrossRefPubMed
51.
Zurück zum Zitat Shen L, Suresh L, Wu J, Xuan J, Li H, Zhang C, Pankewycz O, Ambrus JL: A role for lymphotoxin in primary Sjögren's disease. J Immunol. 2010, 185: 6355-6363. 10.4049/jimmunol.1001520.CrossRefPubMed Shen L, Suresh L, Wu J, Xuan J, Li H, Zhang C, Pankewycz O, Ambrus JL: A role for lymphotoxin in primary Sjögren's disease. J Immunol. 2010, 185: 6355-6363. 10.4049/jimmunol.1001520.CrossRefPubMed
52.
Zurück zum Zitat Durali D, de Goer de Herve MG, Giron-Michel J, Azzarone B, Delfraissy JF, Taoufik Y: In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment. Blood. 2003, 102: 4084-4089. 10.1182/blood-2003-02-0518.CrossRefPubMed Durali D, de Goer de Herve MG, Giron-Michel J, Azzarone B, Delfraissy JF, Taoufik Y: In human B cells, IL-12 triggers a cascade of molecular events similar to Th1 commitment. Blood. 2003, 102: 4084-4089. 10.1182/blood-2003-02-0518.CrossRefPubMed
53.
Zurück zum Zitat Manoussakis MN, Boiu S, Korkolopoulou P, Kapsogeorgou EK, Kavantzas N, Ziakas P, Patsouris E, Moutsopoulos HM: Rates of infiltration by macrophages and dendritic cells and expression of IL-18 and IL-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. Arthritis Rheum. 2007, 56: 3977-3988. 10.1002/art.23073.CrossRefPubMed Manoussakis MN, Boiu S, Korkolopoulou P, Kapsogeorgou EK, Kavantzas N, Ziakas P, Patsouris E, Moutsopoulos HM: Rates of infiltration by macrophages and dendritic cells and expression of IL-18 and IL-12 in the chronic inflammatory lesions of Sjögren's syndrome: correlation with certain features of immune hyperactivity and factors associated with high risk of lymphoma development. Arthritis Rheum. 2007, 56: 3977-3988. 10.1002/art.23073.CrossRefPubMed
54.
Zurück zum Zitat Vosters JL, Landek-Salgado MA, Yin H, Swaim WD, Kimura H, Tak PP, Caturegli P, Chiorini JA: IL-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome. Arthritis Rheum. 2009, 60: 3633-3641. 10.1002/art.24980.PubMedCentralCrossRefPubMed Vosters JL, Landek-Salgado MA, Yin H, Swaim WD, Kimura H, Tak PP, Caturegli P, Chiorini JA: IL-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome. Arthritis Rheum. 2009, 60: 3633-3641. 10.1002/art.24980.PubMedCentralCrossRefPubMed
55.
Zurück zum Zitat Daridon C, Guerrier T, Devauchelle V, Saraux A, Pers JO, Youinou P: Polarization of B effector cells in Sjögren's syndrome. Autoimmun Rev. 2007, 6: 427-431. 10.1016/j.autrev.2007.01.010.CrossRefPubMed Daridon C, Guerrier T, Devauchelle V, Saraux A, Pers JO, Youinou P: Polarization of B effector cells in Sjögren's syndrome. Autoimmun Rev. 2007, 6: 427-431. 10.1016/j.autrev.2007.01.010.CrossRefPubMed
56.
Zurück zum Zitat Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, Burmester GR, Lipsky PE, DDőrner T: Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 2002, 46: 2160-2171. 10.1002/art.10445.CrossRefPubMed Hansen A, Odendahl M, Reiter K, Jacobi AM, Feist E, Scholze J, Burmester GR, Lipsky PE, DDőrner T: Diminished peripheral blood memory B cells and accumulation of memory B cells in the salivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 2002, 46: 2160-2171. 10.1002/art.10445.CrossRefPubMed
57.
Zurück zum Zitat Hansen A, Gosemann M, Pruss A, Reiter K, Ruzickova S, Lipsky PE, DDőrner T: Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome. Arthritis Rheum. 2004, 50: 1897-1908. 10.1002/art.20276.CrossRefPubMed Hansen A, Gosemann M, Pruss A, Reiter K, Ruzickova S, Lipsky PE, DDőrner T: Abnormalities in peripheral B cell memory of patients with primary Sjögren's syndrome. Arthritis Rheum. 2004, 50: 1897-1908. 10.1002/art.20276.CrossRefPubMed
58.
Zurück zum Zitat Hansen A, Daridon C, DDőrner T: What do we know about memory B cells in primary Sjögren's syndrome?. Autoimmun Rev. 2010, 9: 600-603. 10.1016/j.autrev.2010.05.005.CrossRefPubMed Hansen A, Daridon C, DDőrner T: What do we know about memory B cells in primary Sjögren's syndrome?. Autoimmun Rev. 2010, 9: 600-603. 10.1016/j.autrev.2010.05.005.CrossRefPubMed
59.
Zurück zum Zitat Hansen A, Reiter K, Ziprian T, Jacobi A, Hoffmann A, Gosemann M, Scholze J, Lipsky PE, DDőrner T: Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome. Arthritis Rheum. 2005, 52: 2109-2119. 10.1002/art.21129.CrossRefPubMed Hansen A, Reiter K, Ziprian T, Jacobi A, Hoffmann A, Gosemann M, Scholze J, Lipsky PE, DDőrner T: Dysregulation of chemokine receptor expression and function by B cells of patients with primary Sjögren's syndrome. Arthritis Rheum. 2005, 52: 2109-2119. 10.1002/art.21129.CrossRefPubMed
60.
Zurück zum Zitat Xanthou G, Polihronis M, Tzioufas AG, Paikos S, Sideras P, Moutsopoulos HM: "Lymphoid" chemokine mRNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum. 2001, 44: 408-418. 10.1002/1529-0131(200102)44:2<408::AID-ANR60>3.0.CO;2-0.CrossRefPubMed Xanthou G, Polihronis M, Tzioufas AG, Paikos S, Sideras P, Moutsopoulos HM: "Lymphoid" chemokine mRNA expression by epithelial cells in the chronic inflammatory lesion of the salivary glands of Sjögren's syndrome patients: possible participation in lymphoid structure formation. Arthritis Rheum. 2001, 44: 408-418. 10.1002/1529-0131(200102)44:2<408::AID-ANR60>3.0.CO;2-0.CrossRefPubMed
61.
Zurück zum Zitat Salvatore P, Pagliarulo C, Colicchio R, Napoli C: CXCR4-CXCL12-dependent inflammatory network and endothelial progenitors. Curr Med Chem. 2010, 17: 3019-3029. 10.2174/092986710791959792.CrossRefPubMed Salvatore P, Pagliarulo C, Colicchio R, Napoli C: CXCR4-CXCL12-dependent inflammatory network and endothelial progenitors. Curr Med Chem. 2010, 17: 3019-3029. 10.2174/092986710791959792.CrossRefPubMed
62.
Zurück zum Zitat Zheng W, Flavell RA: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997, 89: 587-596. 10.1016/S0092-8674(00)80240-8.CrossRefPubMed Zheng W, Flavell RA: The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells. Cell. 1997, 89: 587-596. 10.1016/S0092-8674(00)80240-8.CrossRefPubMed
63.
Zurück zum Zitat Mackay F, Schneider P, Rennert P, Browning J: BAFF and APRIL: a tutorial on B-cell survival. Annu Rev Immunol. 2003, 21: 231-264. 10.1146/annurev.immunol.21.120601.141152.CrossRefPubMed Mackay F, Schneider P, Rennert P, Browning J: BAFF and APRIL: a tutorial on B-cell survival. Annu Rev Immunol. 2003, 21: 231-264. 10.1146/annurev.immunol.21.120601.141152.CrossRefPubMed
64.
Zurück zum Zitat Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J, Cachero TG, Batten M, Wheway J, Mauri D, Cavill D, Gordon TP, Mackay CR, Mackay F: Association of BAFF/BLyS overexpression and altered B-cell differentiation with Sjögren's syndrome. J Clin Invest. 2002, 109: 59-68.PubMedCentralCrossRefPubMed Groom J, Kalled SL, Cutler AH, Olson C, Woodcock SA, Schneider P, Tschopp J, Cachero TG, Batten M, Wheway J, Mauri D, Cavill D, Gordon TP, Mackay CR, Mackay F: Association of BAFF/BLyS overexpression and altered B-cell differentiation with Sjögren's syndrome. J Clin Invest. 2002, 109: 59-68.PubMedCentralCrossRefPubMed
65.
Zurück zum Zitat Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F, Brink R: Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 2004, 20: 785-798. 10.1016/j.immuni.2004.05.010.CrossRefPubMed Thien M, Phan TG, Gardam S, Amesbury M, Basten A, Mackay F, Brink R: Excess BAFF rescues self-reactive B cells from peripheral deletion and allows them to enter forbidden follicular and marginal zone niches. Immunity. 2004, 20: 785-798. 10.1016/j.immuni.2004.05.010.CrossRefPubMed
66.
Zurück zum Zitat Tengner P, Halse AK, Haga HJ, Jonsson R, Wahren-Herlenius M: Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome. Arthritis Rheum. 1998, 41: 2238-2248. 10.1002/1529-0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V.CrossRefPubMed Tengner P, Halse AK, Haga HJ, Jonsson R, Wahren-Herlenius M: Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren's syndrome. Arthritis Rheum. 1998, 41: 2238-2248. 10.1002/1529-0131(199812)41:12<2238::AID-ART20>3.0.CO;2-V.CrossRefPubMed
67.
Zurück zum Zitat Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, Cooper MD, Browning JL, Sedgwick JD, Cyster JG: LTα/β and TNF are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med. 1999, 189: 403-412. 10.1084/jem.189.2.403.PubMedCentralCrossRefPubMed Ngo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, Cooper MD, Browning JL, Sedgwick JD, Cyster JG: LTα/β and TNF are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med. 1999, 189: 403-412. 10.1084/jem.189.2.403.PubMedCentralCrossRefPubMed
68.
Zurück zum Zitat Fletcher CA, Sutherland AP, Groom JR, Batten ML, Ng LG, Gommerman J, Mackay F: Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells. Eur J Immunol. 2006, 36: 2504-2514. 10.1002/eji.200636270.CrossRefPubMed Fletcher CA, Sutherland AP, Groom JR, Batten ML, Ng LG, Gommerman J, Mackay F: Development of nephritis but not sialadenitis in autoimmune-prone BAFF transgenic mice lacking marginal zone B cells. Eur J Immunol. 2006, 36: 2504-2514. 10.1002/eji.200636270.CrossRefPubMed
69.
Zurück zum Zitat Lemoine S, Morva A, Youinou P, Jamin C: Human T cells induce their own regulation through activation of B cells. J Autoimmun. 2011, 36: 228-238. 10.1016/j.jaut.2011.01.005.CrossRefPubMed Lemoine S, Morva A, Youinou P, Jamin C: Human T cells induce their own regulation through activation of B cells. J Autoimmun. 2011, 36: 228-238. 10.1016/j.jaut.2011.01.005.CrossRefPubMed
70.
Zurück zum Zitat Walters S, Webster KE, Sutherland A, Gardam S, Groom J, Liuwantara D, Marino E, Thaxton J, Weinberg A, Mackay F, Brink R, Sprent J, Grey ST: Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses. J Immunol. 2009, 182: 793-801.CrossRefPubMed Walters S, Webster KE, Sutherland A, Gardam S, Groom J, Liuwantara D, Marino E, Thaxton J, Weinberg A, Mackay F, Brink R, Sprent J, Grey ST: Increased CD4+Foxp3+ T cells in BAFF-transgenic mice suppress T cell effector responses. J Immunol. 2009, 182: 793-801.CrossRefPubMed
71.
Zurück zum Zitat Pers JO, d'Arbonneau F, Devauchelle-Pensec V, Saraux A, Pennec YL, Youinou P: Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome?. Arthritis Rheum. 2005, 52: 2411-2414. 10.1002/art.21205.CrossRefPubMed Pers JO, d'Arbonneau F, Devauchelle-Pensec V, Saraux A, Pennec YL, Youinou P: Is periodontal disease mediated by salivary BAFF in Sjögren's syndrome?. Arthritis Rheum. 2005, 52: 2411-2414. 10.1002/art.21205.CrossRefPubMed
72.
Zurück zum Zitat Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R: The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Ann Rheum Dis. 2003, 62: 168-171. 10.1136/ard.62.2.168.PubMedCentralCrossRefPubMed Mariette X, Roux S, Zhang J, Bengoufa D, Lavie F, Zhou T, Kimberly R: The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjögren's syndrome. Ann Rheum Dis. 2003, 62: 168-171. 10.1136/ard.62.2.168.PubMedCentralCrossRefPubMed
73.
Zurück zum Zitat Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D, Morelli A, Ferraccioli G: Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol. 2008, 35: 1256-1264.PubMed Bosello S, Youinou P, Daridon C, Tolusso B, Bendaoud B, Pietrapertosa D, Morelli A, Ferraccioli G: Concentrations of BAFF correlate with autoantibody levels, clinical disease activity, and response to treatment in early rheumatoid arthritis. J Rheumatol. 2008, 35: 1256-1264.PubMed
74.
Zurück zum Zitat Becker-Merok A, Nikolaisen C, Nossent HC: B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time. Lupus. 2006, 15: 570-576. 10.1177/0961203306071871.CrossRefPubMed Becker-Merok A, Nikolaisen C, Nossent HC: B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time. Lupus. 2006, 15: 570-576. 10.1177/0961203306071871.CrossRefPubMed
75.
Zurück zum Zitat Toubi E, Kessel A, Rosner I, Rozenbaum M, Paran D, Shoenfeld Y: The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus. Scand J Immunol. 2006, 63: 299-303. 10.1111/j.1365-3083.2006.01737.x.CrossRefPubMed Toubi E, Kessel A, Rosner I, Rozenbaum M, Paran D, Shoenfeld Y: The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus. Scand J Immunol. 2006, 63: 299-303. 10.1111/j.1365-3083.2006.01737.x.CrossRefPubMed
76.
Zurück zum Zitat Youinou P, Pers JO: The late news on baff in autoimmune diseases. Autoimmun Rev. 2010, 9: 804-806. 10.1016/j.autrev.2010.06.011.CrossRefPubMed Youinou P, Pers JO: The late news on baff in autoimmune diseases. Autoimmun Rev. 2010, 9: 804-806. 10.1016/j.autrev.2010.06.011.CrossRefPubMed
77.
Zurück zum Zitat Le Pottier L, Bendaoud B, Renaudineau Y, Youinou P, Pers JO, Daridon C: New ELISA for B cell-activating factor. Clin Chem. 2009, 55: 1843-1851. 10.1373/clinchem.2009.129940.CrossRefPubMed Le Pottier L, Bendaoud B, Renaudineau Y, Youinou P, Pers JO, Daridon C: New ELISA for B cell-activating factor. Clin Chem. 2009, 55: 1843-1851. 10.1373/clinchem.2009.129940.CrossRefPubMed
78.
Zurück zum Zitat Lai Kwan Lam Q, King Hung Ko O, Zheng BJ, Lu L: Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci USA. 2008, 105: 14993-14998. 10.1073/pnas.0806044105.PubMedCentralCrossRefPubMed Lai Kwan Lam Q, King Hung Ko O, Zheng BJ, Lu L: Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis. Proc Natl Acad Sci USA. 2008, 105: 14993-14998. 10.1073/pnas.0806044105.PubMedCentralCrossRefPubMed
79.
Zurück zum Zitat Li X: Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling. Cytokine. 2008, 41: 105-113. 10.1016/j.cyto.2007.09.015.CrossRefPubMed Li X: Act1 modulates autoimmunity through its dual functions in CD40L/BAFF and IL-17 signaling. Cytokine. 2008, 41: 105-113. 10.1016/j.cyto.2007.09.015.CrossRefPubMed
80.
Zurück zum Zitat Qian Y, Qin J, Cui G, Naramura M, Snow EC, Ware CF, Fairchild RL, Omori SA, Rickert RC, Scott M, Kotzin BL, Li X: Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity. 2004, 21: 575-587. 10.1016/j.immuni.2004.09.001.CrossRefPubMed Qian Y, Qin J, Cui G, Naramura M, Snow EC, Ware CF, Fairchild RL, Omori SA, Rickert RC, Scott M, Kotzin BL, Li X: Act1, a negative regulator in CD40- and BAFF-mediated B cell survival. Immunity. 2004, 21: 575-587. 10.1016/j.immuni.2004.09.001.CrossRefPubMed
81.
Zurück zum Zitat Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, Xiao J, Lu Y, Giltiay N, Liu J, Kordula T, Zhang QW, Vallance B, Swaidani S, Aronica M, Tuohy VK, Hamilton T, Li X: The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol. 2007, 8: 247-256.CrossRefPubMed Qian Y, Liu C, Hartupee J, Altuntas CZ, Gulen MF, Jane-Wit D, Xiao J, Lu Y, Giltiay N, Liu J, Kordula T, Zhang QW, Vallance B, Swaidani S, Aronica M, Tuohy VK, Hamilton T, Li X: The adaptor Act1 is required for interleukin 17-dependent signaling associated with autoimmune and inflammatory disease. Nat Immunol. 2007, 8: 247-256.CrossRefPubMed
82.
Zurück zum Zitat Lövgren T, Eloranta ML, Båve U, Alm GV, Rönnblom L: Induction of IFN-α production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 2004, 50: 1861-1872. 10.1002/art.20254.CrossRefPubMed Lövgren T, Eloranta ML, Båve U, Alm GV, Rönnblom L: Induction of IFN-α production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum. 2004, 50: 1861-1872. 10.1002/art.20254.CrossRefPubMed
83.
Zurück zum Zitat Mavragani CP, Crow MK: Activation of the type-I IFN pathway in primary Sjögren's syndrome. J Autoimmun. 2010, 35: 225-231. 10.1016/j.jaut.2010.06.012.CrossRefPubMed Mavragani CP, Crow MK: Activation of the type-I IFN pathway in primary Sjögren's syndrome. J Autoimmun. 2010, 35: 225-231. 10.1016/j.jaut.2010.06.012.CrossRefPubMed
84.
Zurück zum Zitat Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, Jacques S, Ba N, Ittah M, Lepajolec C, Labetoulle M, Ardizzone M, Sibilia J, Fournier C, Chiocchia G, Mariette X: Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc Natl Acad Sci USA. 2006, 103: 2770-2775. 10.1073/pnas.0510837103.PubMedCentralCrossRefPubMed Gottenberg JE, Cagnard N, Lucchesi C, Letourneur F, Mistou S, Lazure T, Jacques S, Ba N, Ittah M, Lepajolec C, Labetoulle M, Ardizzone M, Sibilia J, Fournier C, Chiocchia G, Mariette X: Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome. Proc Natl Acad Sci USA. 2006, 103: 2770-2775. 10.1073/pnas.0510837103.PubMedCentralCrossRefPubMed
85.
Zurück zum Zitat Renaudineau Y, Youinou P: Epigenetics and autoimmunity, with special emphasis on methylation. Keio J Med. 2011, 60: 10-16. 10.2302/kjm.60.10.CrossRefPubMed Renaudineau Y, Youinou P: Epigenetics and autoimmunity, with special emphasis on methylation. Keio J Med. 2011, 60: 10-16. 10.2302/kjm.60.10.CrossRefPubMed
86.
Zurück zum Zitat Daridon C, Pers JO, Devauchelle V, Martins-Carvalho C, Hutin P, Pennec YL, Saraux A, Youinou P: Identification of transitional type II B cells in thesalivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 2006, 54: 2280-2288. 10.1002/art.21936.CrossRefPubMed Daridon C, Pers JO, Devauchelle V, Martins-Carvalho C, Hutin P, Pennec YL, Saraux A, Youinou P: Identification of transitional type II B cells in thesalivary glands of patients with Sjögren's syndrome. Arthritis Rheum. 2006, 54: 2280-2288. 10.1002/art.21936.CrossRefPubMed
87.
Zurück zum Zitat Daridon C, Devauchelle V, Hutin P, Le Berre R, Martins-Carvalho C, Bendaoud B, Dueymes M, Saraux A, Youinou P, Pers JO: Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 2007, 56: 1134-1144. 10.1002/art.22458.CrossRefPubMed Daridon C, Devauchelle V, Hutin P, Le Berre R, Martins-Carvalho C, Bendaoud B, Dueymes M, Saraux A, Youinou P, Pers JO: Aberrant expression of BAFF by B lymphocytes infiltrating the salivary glands of patients with primary Sjögren's syndrome. Arthritis Rheum. 2007, 56: 1134-1144. 10.1002/art.22458.CrossRefPubMed
88.
Zurück zum Zitat van de Veerdonk FL, Lauwerys B, Marijnissen RJ, Timmermans K, Di Padova F, Koenders MI, Gutierrez-Roelens I, Durez P, Netea MG, van der Meer JW, van den Berg WB, Joosten LA: The anti-CD20 antibody rituximab reduces the T helper 17 response. Arthritis Rheum. 2011, 63: 1507-1516.CrossRefPubMed van de Veerdonk FL, Lauwerys B, Marijnissen RJ, Timmermans K, Di Padova F, Koenders MI, Gutierrez-Roelens I, Durez P, Netea MG, van der Meer JW, van den Berg WB, Joosten LA: The anti-CD20 antibody rituximab reduces the T helper 17 response. Arthritis Rheum. 2011, 63: 1507-1516.CrossRefPubMed
89.
Zurück zum Zitat Varin MM, Le Pottier L, Youinou P, Saulep D, Mackay F, Pers JO: B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF. Autoimmun Rev. 2010, 9: 604-608. 10.1016/j.autrev.2010.05.006.CrossRefPubMed Varin MM, Le Pottier L, Youinou P, Saulep D, Mackay F, Pers JO: B-cell tolerance breakdown in Sjögren's syndrome: focus on BAFF. Autoimmun Rev. 2010, 9: 604-608. 10.1016/j.autrev.2010.05.006.CrossRefPubMed
90.
Zurück zum Zitat Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, Stenou V, Defrance T, Ajchenbaum-Cymbalista F, Simonin PY, Feldblum S, Kolb JP: Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood. 2004, 103: 679-688. 10.1182/blood-2003-02-0540.CrossRefPubMed Kern C, Cornuel JF, Billard C, Tang R, Rouillard D, Stenou V, Defrance T, Ajchenbaum-Cymbalista F, Simonin PY, Feldblum S, Kolb JP: Involvement of BAFF and APRIL in the resistance to apoptosis of B-CLL through an autocrine pathway. Blood. 2004, 103: 679-688. 10.1182/blood-2003-02-0540.CrossRefPubMed
91.
Zurück zum Zitat DDőrner T, Radbruch A, Burmester GR: B-cell-directed therapies for autoimmune disease. Nat Rev Rheumatol. 2009, 5: 433-441. 10.1038/nrrheum.2009.141.CrossRef DDőrner T, Radbruch A, Burmester GR: B-cell-directed therapies for autoimmune disease. Nat Rev Rheumatol. 2009, 5: 433-441. 10.1038/nrrheum.2009.141.CrossRef
92.
Zurück zum Zitat Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, Vissink A, Kallenberg CG, Bootsma H: Rituximab treatment in patients with Sjögren's syndrome: an open-label phase II study. Arthritis Rheum. 2005, 52: 2740-2750. 10.1002/art.21260.CrossRefPubMed Pijpe J, van Imhoff GW, Spijkervet FK, Roodenburg JL, Wolbink GJ, Mansour K, Vissink A, Kallenberg CG, Bootsma H: Rituximab treatment in patients with Sjögren's syndrome: an open-label phase II study. Arthritis Rheum. 2005, 52: 2740-2750. 10.1002/art.21260.CrossRefPubMed
93.
Zurück zum Zitat Devauchelle-Pensec V, Pennec Y, Morvan J, Pers JO, Daridon C, Jousse-Joulin S, Roudaut A, Jamin C, Renaudineau Y, Quentin-Roue I, Cochener B, Youinou P, Saraux A: Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum. 2007, 57: 310-317. 10.1002/art.22536.CrossRefPubMed Devauchelle-Pensec V, Pennec Y, Morvan J, Pers JO, Daridon C, Jousse-Joulin S, Roudaut A, Jamin C, Renaudineau Y, Quentin-Roue I, Cochener B, Youinou P, Saraux A: Improvement of Sjögren's syndrome after two infusions of rituximab (anti-CD20). Arthritis Rheum. 2007, 57: 310-317. 10.1002/art.22536.CrossRefPubMed
94.
Zurück zum Zitat Dass S, Bowman SJ, Vital EM, Ikeda K, Pease CT, Hamburger J, Richards A, Rauz S, Emery P: Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis. 2008, 67: 1541-1544.CrossRefPubMed Dass S, Bowman SJ, Vital EM, Ikeda K, Pease CT, Hamburger J, Richards A, Rauz S, Emery P: Reduction of fatigue in Sjögren syndrome with rituximab: results of a randomised, double-blind, placebo-controlled pilot study. Ann Rheum Dis. 2008, 67: 1541-1544.CrossRefPubMed
95.
Zurück zum Zitat DDőrner T, Radbruch A, Burmester GR: B-cell-directed therapies for autoimmune disease. Nat Rev Rheumatol. 2009, 5: 433-441. 10.1038/nrrheum.2009.141.CrossRef DDőrner T, Radbruch A, Burmester GR: B-cell-directed therapies for autoimmune disease. Nat Rev Rheumatol. 2009, 5: 433-441. 10.1038/nrrheum.2009.141.CrossRef
Metadaten
Titel
Disturbance of cytokine networks in Sjögren's syndrome
verfasst von
Pierre Youinou
Jacques-Olivier Pers
Publikationsdatum
01.12.2011
Verlag
BioMed Central
Erschienen in
Arthritis Research & Therapy / Ausgabe 4/2011
Elektronische ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3348

Weitere Artikel der Ausgabe 4/2011

Arthritis Research & Therapy 4/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Battle of Experts: Sport vs. Spritze bei Adipositas und Typ-2-Diabetes

11.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Im Battle of Experts traten zwei Experten auf dem Diabeteskongress gegeneinander an: Die eine vertrat die Auffassung „Sport statt Spritze“ bei Adipositas und Typ-2-Diabetes, der andere forderte „Spritze statt Sport!“ Am Ende waren sie sich aber einig: Die Kombination aus beidem erzielt die besten Ergebnisse.

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.